Mariam Jamal-Hanjani

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Mariam Jamal-Hanjani

Aug 18, 2024, 06:12 | Blog

Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC

Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…

Jul 14, 2024, 06:26 | Insight

Daniele Marinelli: NRF2-driven transcription in NSCLC

Daniele Marinelli, PhD student at the Sapienza University of Rome, shared a post on X…

Jun 22, 2024, 13:55 | Insight

"Why do patients with cancer die?" by Adrienne Boire et al.

Recently, Thomas R. Cox, Lab Head of Matrix and Metastasis Lab, shared a post on…

Apr 14, 2024, 07:35 | Drugs

Charles Swanton: What is the role of the TME in lung cancer evolution?

Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…

Apr 11, 2024, 08:18 | Blog

Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation

LUNGevity Foundation shared a post on X: “Mariam Jamal-Hanjani’s talk highlights need for biomarkers to…

Apr 8, 2024, 22:24 | Insight

NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment

A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…

All: 6 Posts: 1 - 100